Virtu Financial’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Virtu Financial’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40K	Buy	+12,908	New	+$53.4K	﹤0.01%	1319
2025 Q2	–	Sell	-687	Closed	-$20K	–	1511
2025 Q1	$20K	Buy	+687	New	+$21.9K	﹤0.01%	1104
2024 Q3	–	Sell	-521	Closed	-$27K	–	1420
2024 Q2	$27K	Buy	+521	New	+$24.6K	﹤0.01%	994
2022 Q4	–	Sell	-144	Closed	-$22K	–	1660
2022 Q3	$22K	Sell	144 -138	-49%	-$23.9K	﹤0.01%	1372
2022 Q2	$52K	Buy	+282	New	+$54.1K	﹤0.01%	1114
2021 Q2	–	Sell	-231	Closed	-$114K	–	1547
2021 Q1	$114K	Sell	231 -139	-38%	-$60.3K	0.01%	1282
2020 Q4	$132K	Buy	370 +302	+444%	+$110K	0.01%	984
2020 Q3	$24K	Sell	68 -91	-57%	-$38K	﹤0.01%	906
2020 Q2	$63K	Buy	+159	New	+$58.5K	0.01%	976
2018 Q4	–	Sell	-9	Closed	-$35K	–	1583
2018 Q3	$35K	Buy	+9	New	+$33.7K	﹤0.01%	1350
2018 Q1	–	Sell	-7	Closed	-$29K	–	1998
2017 Q4	$29K	Buy	7 +3	+75%	+$13.7K	﹤0.01%	2165
2017 Q3	$19K	Buy	+4	New	+$20.6K	﹤0.01%	2356

Other funds holding CANF

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Virtu Financial's CANF Position: Q1 2026 in Review

Virtu Financial opened a new position in Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2026: 12,908 shares worth $40K. The stake represents ﹤0.01% of the portfolio and ranks #1319 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CANF as recently as Q1 2025.

Virtu Financial first reported a position in CANF in Q3 2017 and has held it in 12 quarters since. The position peaked at $132K in Q4 2020. 14 funds tracked by Wall St. Rank hold CANF as of Q1 2026.

Virtu Financial held 12,908 shares of Can-Fite BioPharma American Depositary Shares worth $40K as of Q1 2026.
Can-Fite BioPharma American Depositary Shares was a new Virtu Financial position in Q1 2026.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1319 holding.
Virtu Financial first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2017 and has held it in 12 quarters since.
Virtu Financial's Can-Fite BioPharma American Depositary Shares position peaked at $132K in Q4 2020.
14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.